The global epilepsy monitoring devices market size was estimated at USD 559.0 million in 2023 and is projected to grow at a CAGR of 6.6% from 2024 to 2030. The market is driven by several factors, such as the increasing prevalence of epilepsy, advances in technology, growing demand for ambulatory monitoring, rising use of wearable devices, and growing government initiatives.

Further, the increasing need for improved diagnosis and treatment, growing competition, and growing importance of telemedicine are also some of the primary factors fueling the market growth. The prevalence of epilepsy is increasing globally, with a significant number of people affected worldwide.

Epilepsy is a neurological disorder that affects an estimated 50 million people worldwide, making it one of the most common chronic conditions globally, according to the World Health Organization (WHO). According to the same report, around 80% of people with epilepsy live in low- and middle-income countries (LMIC), where access to quality healthcare is often limited. The condition is characterized by recurring seizures, which can have a significant impact on a person's quality of life. Effective diagnosis and treatment of epilepsy require advanced monitoring devices that can detect and track seizures in real-time.

In the U.S. alone, over 3 million individuals are estimated to be living with epilepsy. Further, in 2021, about 2.9 million U.S. adults 18 and older reported having active epilepsy, as per the U.S. Centers for Disease Control and Prevention.

Gather more insights about the market drivers, restrains and growth of the Global Epilepsy Monitoring Devices Market

The advancement of wearable technology and data analytics has revolutionized the field of epilepsy monitoring devices. The introduction of smartwatches and fitness trackers equipped with seizure detection algorithms has enabled the continuous monitoring of a patient's physiological data, including heart rate, movement, and electrodermal activity. This allows for detecting potential seizure episodes in real-time, providing patients and healthcare providers with timely and accurate information to make informed decisions about treatment and management. For instance, in February 2024, Empatica Inc., a pioneering company in continuous, non-invasive, and discreet monitoring for neurological conditions, announced the launch of EpiMonitor. This latest innovation in wearable epilepsy monitoring solutions is designed for adults and children aged 6 and above, offering cutting-edge technology that provides unparalleled convenience and accuracy in detecting and managing seizures.

Furthermore, growing government initiatives such as funding and investments for epilepsy research are expected to fuel the market's growth over the forecast period. For instance, Epilepsy Research Institute UK announced that the UK government has invested over USD 1.89 million in grant funding into Epilepsy Research UK through its Medical Research Charities Early Career Researchers Support Fund. The charity received USD 1.35 million in 2022-23 and USD 562,010.5 in 2021-22. Further, in March 2024, the British Epilepsy Association announced a USD 48.66 million investment into research for cancer, dementia, and epilepsy.

Regional Insights

The North America epilepsy monitoring devices market is expected to experience significant growth over the forecast period, driven by the increasing prevalence of epilepsy, advancements in technology, and growing demand for non-invasive monitoring solutions. Key players in the North American market include Medtronic, GE Healthcare, and Masimo. These companies are investing heavily in research and development to improve the accuracy and effectiveness of their devices. In recent years, there has been a shift towards miniaturization of devices, allowing for greater patient comfort and increased mobility. In addition, advancements in artificial intelligence (AI) and machine learning (ML) are being used to improve seizure detection and prediction.

Key Epilepsy Monitoring Devices Company Insights

The epilepsy monitoring device market is highly competitive, with multiple players vying for dominance. The market is characterized by intense competition among established players, new entrants, and emerging companies. The key companies have a strong presence in the market, with a wide range of products and solutions catering to different market segments. Companies focus on developing innovative products that offer better accuracy, convenience, and ease of use.

Further, new entrants in the market include Empatica Inc. and Neurava, among others. These companies are focused on developing innovative products that address specific market needs.

 

Key Epilepsy Monitoring Devices Companies:

The following are the leading companies in the epilepsy monitoring devices market. These companies collectively hold the largest market share and dictate industry trends.

  • NIHON KOHDEN CORPORATION
  • Medtronic
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Compumedics Limited
  • Natsu Medical
  • Cadwell Industries, Inc.
  • BrainScope Company, Inc.
  • Seer Medical
  • Stratus

Order a free sample PDF of the Epilepsy Monitoring Devices Market Intelligence Study, published by Grand View Research.